60 results on '"Theodorescu, Dan"'
Search Results
2. Single-Cell Profiling of Murine Bladder Cancer Identifies Sex-Specific Transcriptional Signatures with Prognostic Relevance
3. Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314
4. Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients
5. Sex-biased adaptive immune regulation in cancer development and therapy
6. The origin of bladder cancer from mucosal field effects
7. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
8. Re: Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
9. Synthesis of novel Ral inhibitors: An in vitro and in vivo study
10. An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression
11. Pharmacogenomics
12. Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward
13. Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum
14. Re: Phase II Trial of Cetuximab with or Without Paclitaxel in Patients with Advanced Urothelial Tract Carcinoma
15. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
16. Telomerase in Bladder Cancer: Back to a Better Future?
17. Pharmacogenomics in bladder cancer
18. Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression
19. ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings
20. Permissive role of endothelin receptors in tumor metastasis
21. Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?
22. Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status
23. Perspectives on personalized cancer care
24. Cyclophilin B Expression Is Associated with In Vitro Radioresistance and Clinical Outcome after Radiotherapy
25. In vitro transcriptomic prediction of hepatotoxicity for early drug discovery
26. RREB1 Transcription Factor Splice Variants in Urologic Cancer
27. A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment
28. Use of Yeast Chemigenomics and COXEN Informatics in Preclinical Evaluation of Anticancer Agents
29. RalBP1 Is Necessary for Metastasis of Human Cancer Cell Lines
30. Re: Mortality Results from the Göteborg Randomised Population-Based Prostate-Cancer Screening Trial
31. Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
32. Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
33. RhoGDI signaling provides targets for cancer therapy
34. Genoproteomic Mining of Urothelial Cancer Suggests γ-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy
35. Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer
36. Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
37. Profiling Bladder Cancer Organ Site-Specific Metastasis Identifies LAMC2 as a Novel Biomarker of Hematogenous Dissemination
38. The Ral GTPase pathway in metastatic bladder cancer: Key mediator and therapeutic target
39. Cdc6 and Cyclin E2 Are PTEN-Regulated Genes Associated with Human Prostate Cancer Metastasis
40. Molecular Credentialing of Rodent Bladder Carcinogenesis Models
41. RhoGDI2: A new metastasis suppressor gene: Discovery and clinical translation
42. Re: Postoperative Nomogram Predicting Risk of Recurrence after Radical Cystectomy for Bladder Cancer
43. A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer
44. Case-Matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer
45. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis
46. Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer
47. Brachytherapy for prostate cancer
48. Follow-up strategies and management of recurrence in urologic oncology
49. The Impact of Prostate Volume Following Neoadjuvant Androgen Deprivation on Quality of Life and Voiding Symptoms in Patients Undergoing Permanent Prostate Brachytherapy
50. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.